COMPANY PROFILE / #2248
AI Proteins
Boston, MAVenture Capital-Backed
OVERVIEW
Operator of a protein engineering platform intended to create synthetic proteins for therapeutic development. The company offers artificial intelligence-based protein design and high-throughput drug discovery capabilities, enabling biotechnology and pharmaceutical companies to develop durable, specific, and optimized protein therapeutics for targeted medical applications.
已融资59.70
最新估值75.00
员工数34
成立年份2021
公司概况
- Companies
- AI Proteins
- Description
- Operator of a protein engineering platform intended to create synthetic proteins for therapeutic development. The company offers artificial intelligence-based protein design and high-throughput drug discovery capabilities, enabling biotechnology and pharmaceutical companies to develop durable, specific, and optimized protein therapeutics for targeted medical applications.
- Website
- aiproteins.com
- HQ Location
- Boston, MA
- Year Founded
- 2021
- Keywords
- biotechnology ai, biotechnology company, biotechnology research, laboratory robotics, life-changing medicine, pharma company, pharmaceutical company
- Competitors
- Lila, Wild Biotech, Ordaos, Neoleukin Therapeutics, Aktis Oncology, Mopac Biologics, Arcellx
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 59.70
- First Financing Date
- 11-Jan-2022
- First Financing Size
- 18.20
- First Financing Valuation
- 38.00
- Last Financing Date
- 12-Nov-2025
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- 41.50
- Last Financing Valuation
- 75.00
- Last Financing Status
- Completed
- Last Known Valuation
- 75.00
- Last Known Valuation Date
- 12-Nov-2025
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 118.91
- Valuation Estimate Growth Rate
- 58.54%
- Active Investors
- Cobro Ventures, Impact Assets, Lightchain Capital, Mission BioCapital, Santé Ventures, Tachyon Ventures
- # Active Investors
- 6
- Acquirers
- —
团队与联系人
- Employees
- 34
- Employee Growth %
- 6.25%
- Employee History
- 2026: 34, 2025: 32, 2024: 32, 2023: 29, 2022: 19, 2021: 11
- Primary Contact
- Julia Novina
- Primary Contact Title
- Chief Legal Officer & Vice President of General Counsel
- Primary Contact Email
- julia.novina@aiproteinstx.com
- Primary Contact Phone
- +1 (617) 412-6117
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.19%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 91
- Size Multiple
- 3.16x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 76
- Majestic Referring Domains
- 54
- SimilarWeb Unique Visitors
- 1,064
- SimilarWeb Unique Visitors Change
- 111
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 4%
- Success Probability Over Time – 3 Year
- 17%
- Success Probability Over Time – 5 Year
- 31%
记录来源：public.companies · 原始序号 #2248 · 所有字段均按数据库原值展示。